Skip to main content
. 2019 Feb 23;41:384–394. doi: 10.1016/j.ebiom.2019.02.032

Fig. 6.

Fig. 6

BMI1 level correlates with FUNDC1 level in progression of clinical BC. (a–c) Correlation between FUNDC1 and BMI1 mRNA expression for clinical BC patient data from the indicated online databases. (d) Representative immunohistochemical co-staining for FUNDC1 and BMI1 protein in continuous slices of BC tissue. (e) Scatter diagram showing overall survival time for patients with co-expression of FUNDC1 and BMI1 protein. (d–e) Kaplan-Meier analysis of overall survival in patients with high level of FUNDC1 and BMI1 co-expression predicting worse progression of clinical BC.